TCR2 Therapeutics Inc.
TCRRDelisted Jun 1, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001750019
TCR2 Therapeutics Inc. was delisted on Jun 1, 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.5M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in TCR2 Therapeutics Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 122
- +8 vs. Q3 2021
- Shares held
- 29.2M
- −2.10M (−6.7%) vs. Q3 2021
- Total value
- $136.0M
- −$130.4M (−49.0%) vs. Q3 2021
- New holders
- 40
- 34 more added
- Sold out
- 32
- 35 more reduced
3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 59 | $31.5M |
| Q4 2022 | 63 | $21.2M |
| Q3 2022 | 81 | $45.1M |
| Q2 2022 | 83 | $72.2M |
| Q1 2022 | 94 | $74.8M |
| Q4 2021 | 122 | $136.0M |
| Q3 2021 | 117 | $271.1M |
| Q2 2021 | 119 | $575.3M |
| Q1 2021 | 129 | $834.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding TCR2 Therapeutics Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 350,000 | $1.63M | 0.01% | +350,000 | New |
| Parametric Portfolio Associates LLC | 364,726 | $1.70M | 0.00% | +291,040+395.0% | Added |
| ArrowMark Colorado Holdings LLC | 428,088 | $2.00M | 0.02% | −785,410−64.7% | Reduced |
| D. E. Shaw & Co., Inc. | 443,757 | $2.07M | 0.00% | +443,757 | New |
| Morgan Stanley | 448,330 | $2.09M | 0.00% | +318,953+246.5% | Added |
| Citadel Advisors LLC | 514,501 | $2.40M | 0.00% | +139,492+37.2% | Added |
| State Street Corp | 515,189 | $2.40M | 0.00% | −999,528−66.0% | Reduced |
| Two Sigma Advisers, LP | 593,400 | $2.77M | 0.01% | +402,900+211.5% | Added |
| Geode Capital Management, LLC | 621,452 | $2.90M | 0.00% | +167,119+36.8% | Added |
| Artal Group S.A. | 750,000 | $3.50M | 0.10% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 753,064 | $3.51M | 0.02% | +576,603+326.8% | Added |
| Two Sigma Investments, LP | 764,404 | $3.56M | 0.01% | +442,545+137.5% | Added |
| Wellington Management Group LLP | 835,327 | $3.89M | 0.00% | −1,909,849−69.6% | Reduced |
| Renaissance Technologies LLC | 891,900 | $4.16M | 0.01% | +698,100+360.2% | Added |
| JPMorgan Chase & Co | 930,835 | $4.34M | 0.00% | −99,525−9.7% | Reduced |
| Bank of America Corp | 1,229,279 | $5.73M | 0.00% | +1,132,206+1,166.3% | Added |
| Redmile Group, LLC | 1,346,058 | $6.27M | 0.14% | −2,470,651−64.7% | Reduced |
| Vanguard Group Inc | 1,350,777 | $6.29M | 0.00% | −103,295−7.1% | Reduced |
| Millennium Management LLC | 1,445,317 | $6.74M | 0.01% | +1,156,650+400.7% | Added |
| BlackRock Inc. | 2,401,745 | $11.2M | 0.00% | −562,900−19.0% | Reduced |
| MPM Oncology Impact Management LP | 3,370,982 | $15.7M | 2.86% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,050,865 | $18.9M | 4.08% | 00.0% | Unchanged |
| First Light Asset Management, LLC | 0 | $0 | 0.00% | −620,887−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −479,506−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −477,323−100.0% | Sold out |
| Rothschild & Co Asset Management US Inc. | 0 | $0 | 0.00% | −348,395−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −235,808−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −147,600−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −114,844−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −85,331−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −71,283−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −59,150−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −54,500−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −54,260−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −42,084−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −37,785−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −35,700−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −18,349−100.0% | Sold out |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 0 | $0 | 0.00% | −15,521−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −14,658−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −13,556−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −13,419−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −13,100−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −11,762−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −11,591−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −9,153−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −3,580−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −1,472−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −875−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −642−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −103−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |
| First Mercantile Trust Co | – | – | – | – | Not filed |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |